BMS tops list of sustainability stars

Four pharmaceutical companies have exceeded the 50 percent mark in an analysis of the voluntary sustainability reporting. Bristol-Myers Squibb, Sanofi-Aventis, Abbott Labs and Johnson & Johnson took top honors among Fortune 500 pharmaceutical companies.

Lowest scores went to Forest Labs, NBTY and King Pharmaceuticals. The analysis was done by the Roberts Environmental Center (REC) at Claremont McKenna College.

The analysis combines environmental and social reports under the heading of sustainability. The top scorers, according to the report, provide extensive reports and Internet pages detailing the company's impact, vision, programs and goals. Those with the lowest scores rarely mention corporate responsibility.

The pharma industry, like most others, did the least reporting on environmental performance.

- here's the report

Suggested Articles

Cadila Healthcare is looking for outside manufacturing partners to add 70 million doses of its experimental COVID-19 vaccine to its arsenal.

The COVID-19 pandemic has disrupted another biopharma company's plan to launch a new medicine.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.